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Abstract
Background
The disease burden is increasing for chronic obstructive pulmonary disease (COPD) due to
increasing of the growth rate of prevalence and mortality. But the empirical researches are a
little for COPD that studied the association between continuity of care and death and about
predictors effect on mortality.
Objective
To investigate the association between continuity of care (COC) and chronic obstructive
pulmonary disease (COPD) mortality and to identify other mortality-related factors in COPD
patients.
Methods
We conducted a longitudinal, population-based retrospective cohort study in adult patients
with COPD from 2002 to 2012 using a nationwide health insurance claims database. The
study sample included individuals aged 40 years and over who developed COPD in 2005
and survived until 2006. We performed a Cox proportional hazard regression analysis with
COC analyzed as a time-dependent covariate.
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Results
Of the 3,090 participants, 60.8% died before the end of study (N = 1,879). The median years
of survival for individuals with high COC (COC index0.75) was 3.92, and that for patients
with low COC (COC index<0.75) was 2.58 in a Kaplan Meier analysis. In a multivariate, time-
dependent analysis, low COCwas associated with a 22% increased risk of all-cause mortality
(HR, 1.22; 95% CI, 1.09–1.36). Not receiving oxygen therapy at home was associated with a
23% increased risk of all-cause mortality (HR, 1.23; 95% CI, 1.01–1.49). Moreover, the risk of
all-cause mortality for individuals who admitted one time increased 38% (HR, 1.38; 95% CI,
1.21–1.59), two times was 63% (HR, 1.63; 95% CI, 1.34–1.99) and 3+ times was 96% (HR,
1.96; 95% CI, 1.63–2.36) relative to the reference group (no admission).
Conclusions
High COC was associated with a decreased risk of all-cause mortality. In addition, home
oxygen therapy and number of hospital admissions may predict mortality in patients with
COPD.
Introduction
As many societies age, the prevalence of chronic diseases is increasing. The burden of disease is
shifting from communicable diseases to non-communicable diseases in developed countries.
Policymakers worldwide are beginning to recognize the magnitude of the problem. To effi-
ciently manage chronic diseases with limited resources, policymakers are becoming interested
in the benefits of continuity of care (COC), which can reduce the risk of complications [1],
improve preventive care [2, 3], increase patients satisfaction [4] and compliance [5, 6], and
decrease emergency and inpatient medical services and care costs [7–12]. In primary care,
especially, COC is being introduced to improve quality and to cope with the increased work-
load associated with chronic diseases [13].
Continuity can be defined from various perspectives: informational continuity; manage-
ment continuity; and relational continuity, or an ongoing therapeutic relationship between a
patient and one or more providers [14]. Relational continuity, in particular, can reinforce care
in patients with chronic conditions, because a continuous provider is more likely to know
when tests are needed and treatment changes are indicated [15]. Relational continuity refers to
a special type of longitudinal continuity; the latter implies a pattern of visits but does not
directly address the nature of the relationship between patient and provider [16].
The Korean health care delivery system is classified into three steps based on fee-for-service
as the reimbursement mechanism: clinics function as primary care institutions, hospitals func-
tion as secondary care institutions, and general hospitals and tertiary general hospitals function
as third tier care institutions. All of these can provide outpatient services. Korea’s system is
quite different from the managed care delivery system of the US where a patient’s selection of
health care provider is regulated and restricted. Above all, because most clinical practitioners
in Korea are specialists, they do not perform the function of a primary care physician as seen in
the US [17]. In Korea, primary care physicians typically work in solo private practices and are
reimbursed on a fee-for-service basis. In terms of outpatient services, clinics compete against
other clinics, hospitals, and some general hospitals. Given the context, universal coverage pro-
vided by National Health Insurance has improved the accessibility of medical care but this sys-
tem enables patients to choose freely and lead to the high number of fragmented visits.
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Chronic obstructive pulmonary disease (COPD) is one common chronic disease, and its
prevalence continues to rise. Worldwide, disability-adjusted life years (DALYs) associated with
COPD increased 45.9% from 1990 to 2010 [18]. In Korea, the incidence of chronic lower respi-
ratory diseases increased 11.2% from 2011 to 2012 [19], and the prevalence of COPD increased
from 2.5 per 100,000 people in 2007 to 7.2 people per 100,000 in 2012. Many previous studies
have found associations between COC and health outcomes such as diabetes mellitus, hyper-
tension, pediatric asthma, and some psychiatric disorders. There are fewer studies on COPD
on diseases such as diabetes or hypertension, however. Moreover, studies involving long-term
follow-up of COPD patients and survival are rare. Previous studies of COPD have shown that
age, forced expiratory volume in one second (FEV1), body mass index, oxygen therapy, smok-
ing history, number of previous hospital admissions, and number of emergency department
visits are strongly associated with mortality [20–23].
The first aim of this study was to measure COC over 7 years in patients with COPD and to
investigate the association between COC and mortality. The second aim was to examine other
potential predictors of mortality in COPD patients, such as oxygen therapy and number of pre-
vious hospitalizations.
Methods
Data and study design
This study used the Korean National Health Insurance Service (KNHIS) claims database for
2002–2012. We conducted a retrospective cohort study of new adult COPD patients to investi-
gate the association between continuity of ambulatory care and mortality over the 7-year follow
up period. Participants were 40 years of age or older with newly diagnosed COPD, codes J43
and J44 (International Classification of Disease, 10th edition [ICD-10]). That the diagnosis was
new was confirmed by the lack of COPD claims in 2002–2004 and a first COPD claim in 2005.
We measured continuity of ambulatory care for 7 years, and observed mortality from 2006 to
2012. Ethical approval for this study was granted by the Institutional Review Board of the
Graduate School of Public Health, Yonsei University. The requirement for informed consent
was waived because the study was based on routinely collected administrative and claims data.
Patient information and records was de-identified prior to analysis.
Study population
The total number of individuals with COPD 40 years or older was 1,538,711 during 2002–
2012. Of these, 138,680 patients received their diagnosis in 2005. We excluded 135,590 patients
with less than four outpatient visits per year in 2006–2012. This criterion was intended to facili-
tate calculation of the COC index in a structurally reasonable and meaningful manner. Another
rationale for this criterion was to improve the accuracy of COPD diagnosis. We obtained
COPD diagnoses from data, which are based on information from the KNHIS claims database.
The accuracy of diagnosis in KNHIS claims data is roughly 70% [24]. In our study, we defined
‘outpatient visit’ that COPD patient only visited due to COPD as ICD-10 code, J43 or J44. We
excluded visits which patient utilized outpatient services due to diabetes, hypertension, or the
other diseases. When calculating COC index, we limited outpatient visits due to COPD. Thus,
we needed a process to aid in the selection of participants that actually had COPD. Frequent
COPD-related visits ensured that we included only patients with a valid diagnosis. Using these
criteria, the final study sample included 3,090 participants.
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Variables
The dependent variable in this study was mortality. We defined mortality to include all causes
of death, on the basis of information recorded in the KNHIS database.
We defined continuity as longitudinal continuity in this study. Thus, we calculated the COC
index in subjects with four or more ambulatory care visits per year [25]. This is because in a
country where over 90% of clinical practitioners are specialists, during 2006–2012, we mea-
sured the COC for each patient using the COC index. The COC index reflects the distribution
of visits to different healthcare institutions. It is influenced by both the total number of provid-
ers and the total number of visits. The index ranges from 0 to 1; a higher value corresponds to
better COC. The formula for the COC index is as follows:
coc ¼
P
nj
2  N
NðN 1Þ ð1Þ
where N is the total number of ambulatory care visits, nj is the number of visits to the jth pro-
vider. In this study, ‘potentially available providers’ refers not to medical physicians but to
healthcare institutions. A COC score of 1 indicates that all visits were to the same provider. We
deﬁned high COC as a score>0.75, consistent with a previous study [26].
Covariates considered included age, sex, health insurance status (national health insurance,
medical aid), Charlsons’ comorbidity index (0, 1, 2+), home oxygen therapy (yes, no), use of
intensive care unit (ICU) medical service (yes, no), number of hospital admissions (0, 1, 2, 3+),
and respiratory impairment grade (1, 2, 3, none); all of these variables were measured at the
2006 baseline. In the case of health insurance, people can qualify for medical aid if their house-
hold income is less than $600 per month based on single household. Respiratory impairment
grade was defined using %FEV1, Pa,O2 and dyspnea. Grade 1 was defined as patients with an %
FEV1 lower than 25% or Pa,O2 less than 55 mmHg while having difficulty breathing at rest;
Grade 2 was defined as patients with %FEV1 lower than 30% or Pa,O2 less than 60mmHg while
having difficulty breathing at moving in the home; Grade 3 was defined as patients with %
FEV1 lower than 40% or Pa,O2 less than 65 mmHg while having difficulty at walking on flat.
Respiratory impairment grade was defined using FEV1 and dyspnea. Only the comorbidity
component of Charlsons’ comorbidity index was calculated, and all diagnostic information was
collected from inpatient and outpatient billing data for 2006.
Statistical analysis
In this analysis, participants were censored based on survival to the end of the study. We
divided participants into two groups based on censored status, and compared the distributions
of each variable of interest between the groups using chi-square and t-tests. Unadjusted median
years of survival were estimated using the Kaplan-Meier method, and adjusted median years of
survival were estimated using the Cox proportional hazard model with the Breslow method.
This type of model was also used to identify factors associated with mortality. To avoid time-
dependent bias [27], the COC index was treated as a time-dependent variable over the 7-year
observed mortality period. Thus, we constructed a Cox proportional hazard model with time-
dependent covariates to model the effect of COC on mortality. In this model, the previous
year’s COC index reflected the next year’s survival. The log of cumulative hazard rates was pro-
portional to the follow-up time, and no violations of the proportional hazard assumption were
detected. All statistical analyses were performed using SAS statistical software (version 9.3).
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Results
In this study, 60.8% of participants died prior to the end of the study. Table 1 presents the char-
acteristics of the study sample at baseline (2006), stratified by censored status. The mean age of
the sample was 69.0 years. The two groups were significantly different with respect to all char-
acteristics measured, except for sex, home oxygen therapy, and ICU use.
Unadjusted and adjusted median years of survival stratified by home oxygen therapy status
are presented in Fig 1. The adjusted median years of survival for patients receiving home oxy-
gen therapy was 4.92 years, and that for patients not receiving home oxygen therapy was 3.58
years. This difference was statistically significant (P = 0.04). In addition, unadjusted and
adjusted median years of survival decreased as number of hospital admissions increased (Fig
2). Unadjusted median years of survival for 0/1/2/3+ hospital admissions were 4.17/2.42/2.08/
1.50, respectively (P = 0.001), and adjusted median years of survival were 4.25/2.58/2.17/1.65
(P = 0.01). Unadjusted median years of survival were shortest for individuals with no respira-
tory impairment grade, at 3.17 years (Fig 3). However, after controlling for covariates, median
Table 1. Baseline characteristics of the study population according to death.
All patients Without death With death P-value
Characteristics (N = 3,090) (N = 1,211) (N = 1,879)
Age (years), mean (SD) 69.0 (10.1) 64.4 (9.3) 71.9 (9.5) < .0001
Sex, n (%)
Male 2,348 930 (76.8) 1,418 (75.5) 0.398
Female 742 281 (23.2) 461 (24.5)
Health insurance type, n (%)
National health insurance 1,857 768 (41.4) 1,089 (58.6) 0.003
Medical aid 1,233 443 (35.9) 790 (64.1)
Home oxygen therapy, n (%)
Yes 182 69 (37.3) 116 (62.7) 0.586
No 2,908 1142 (39.3) 1,763 (60.7)
Charlson comorbidity index, n (%)a
0 2,180 459 (39.6) 699 (60.4) 0.107
1 708 687 (39.7) 1,043 (60.3)
2 202 65 (32.2) 137 (67.8)
ICU use, n (%)
Yes 46 12 (26.1) 34 (73.9) 0.067
No 3,044 1,199 (39.4) 1,845 (60.6)
Number of hospital admission, n (%)
0 2,416 1,037 (42.9) 1,379 (57.1) < .0001
1 347 96 (27.7) 251 (72.3)
2 157 43 (27.4) 114 (72.6)
3 170 35 (20.6) 135 (79.4)
Respiratory impairment grade, n (%)
Grade 1 (%FEV125 or Pa,O2 <55 mmHg) 168 69 (41.1) 99 (58.9) 0.016
Grade 2 (%FEV135 or Pa,O2 <60 mmHg) 172 74 (43.0) 98 (57.0)
Grade 3 (%FEV140 or Pa,O2 <65 mmHg) 185 91 (49.2) 94 (50.8)
None (%FEV1 and Pa,O2 = Normal) 2,565 977 (38.1) 1,588 (61.9)
ICU, Intensive Care Unit; %FEV1, FEV1 predicted
aCalculated comorbidity scores; extracted age scores.
doi:10.1371/journal.pone.0141465.t001
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Fig 1. Median years of survival, stratified according to home oxygen therapy status (n = 3,090). (A) Kaplan-Meier survival plot for patients with newly
diagnosed COPD over 6 years of follow-up: HOT* = No-Median 5.08yrs; HOT* = Yes- Median 5.25 yrs (B) Adjusted Cox’s proportional hazards regression
plot: HOT* = No- Median 3.58yrs; HOT* = Yes- Median 4.92 yrs. *, Home oxygen therapy.
doi:10.1371/journal.pone.0141465.g001
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years of survival were shortest for respiratory impairment grade 1 patients, at 2.33 years.
Finally, unadjusted median years of survival for participants with high COC were greater than
for participants with low COC (3.92 and 2.58 years, respectively), and adjusted median years of
survival displayed the same relationship (4.00 and 2.92 years, respectively; Fig 4).
The mortality hazard ratio increased with age (HR, 1.06; 95% CI, 1.05–1.07) after control-
ling for covariates including age, sex, health insurance type, use of home oxygen therapy,
Charlson comorbidity index, ICU use, Number of hospital admission, and respiratory
impairment grade. In addition, the adjusted mortality hazard ratio was significantly higher for
individuals who did not receive home oxygen therapy (HR, 1.21; 95% CI, 1.01–1.47), The
adjusted hazard ratio also increased with the number of hospital admissions; the adjusted haz-
ard ratios for individuals with 1, 2, and 3 or more admissions relative to the reference group
(0 admissions) were 1.38 (95% CI, 1.20–1.58), 1.60 (95% CI, 1.31–1.96), and 1.94 (95% CI,
Fig 2. Median years of survival, stratified according to number of hospital admissions (n = 3,090). (C)
Kaplan-Meier survival plot for patients with newly diagnosed COPD over 6 years of follow-up: 3+ Admission-
Median 1.50 yrs; 2 Admission-Median 2.08 yrs; 1 Admission-Median 2.42 yrs; 0 Admission- Median 4.17 yrs.
(D) Adjusted Cox’s proportional hazards regression plot: 3+ Admission-Median 1.65 yrs; 2 Admission-
Median 2.17 yrs; 1 Admission-Median 2.58 yrs; 0 Admission-Median 4.25 yrs.
doi:10.1371/journal.pone.0141465.g002
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Fig 3. Median years of survival, stratified according to respiratory disability grade (n = 3,090). (E) Kaplan-Meier survival plot for patients with newly
diagnosed COPD over 6 years of follow-up: Grade 1-Median 3.83 yrs; Grade 2-Median 4.50 yrs; Grade 3-Median 5.67 yrs; None-Median 3.17 yrs. (F)
Adjusted Cox’s proportional hazards regression plot: Grade 1- Median 1.65 yrs; Grade 2-Median 2.17 yrs; Grade 3-Median 2.58 yrs; None-Median 4.25 yrs.
doi:10.1371/journal.pone.0141465.g003
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1.60–2.34), respectively. Moreover, relative to individuals with no respiratory disability, the
adjusted hazard ratio was 1.42 (95% CI, 1.14–1.77) for those with grade 1 respiratory disability,
1.17 (95% CI, 0.94–1.45) for those with grade 2 disability, and 0.99 (95% CI, 0.80–1.22) for
those with grade 3 disability. Finally, in a time-dependent Cox regression analysis adjusted for
patient characteristics, COC was significantly associated with mortality. Low COC (COC
index< 0.75) was associated with a 22% increased risk of all-cause death in any given year
(adjusted HR, 1.22; 95% CI, 1.09–1.36; Table 2).
Discussion
We found that COPD patients with higher COC had a lower risk of mortality. Low COC was
associated with 22% higher mortality. We also found that home oxygen therapy was associated
Fig 4. Median years of survival, stratified according to COC, which was treated as a time-dependent
covariate (n = 3,090). (G) Plot for patients with newly diagnosed COPD over 6 years of follow-up using
Breslow method; COC† <0.75-Median 2.58 yrs; COC†0.75-Median 3.92 yrs. (H) Adjusted Cox’s
proportional hazards regression plot: COC† <0.75- Median 2.92 yrs; COC†0.75; Median 4.00 yrs. †,
Continuity of care.
doi:10.1371/journal.pone.0141465.g004
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with a 21% decreased risk of mortality and that risk of mortality increased with number of vis-
its to the hospital admission department.
We could not find the previous research that investigated the association between COC and
mortality in patients with COPD documented in this study. However, in perspective that high
COC lead to good health outcome, our result is consistent with previous studies of COC and
outcomes in COPD patients [12, 28]. Our study did not reveal the mechanism underlying
these results, but there are some possible explanations in terms of two contrasted aspects. First,
Gray et al. have suggested that COC could benefit patients by reinforcing accumulation of
Table 2. Hazard ratio for death by Cox’s proportional model.
HRs for 7-year mortality (95% CI)
Characteristics Unadjusted Adjusteda
Age (years) 1.06 (1.05–1.06) 1.06 (1.05–1.07)
Sex
Male 091 (0.82–1.02) 1.06 (0.95–1.19)
Female 1.00 1.00
Health insurance type
National health insurance 1.00 1.00
Medical aid 1.13 (1.03–1.25) 1.05 (0.95–1.15)
Home oxygen therapy
Yes 1.00 1.00
No 1.12 (0.92–1.35) 1.21 (1.01–1.47)
Charlson comorbidity indexb
0 1.00 1.00
1 0.98 (0.89–1.08) 0.94 (0.85–1.04)
2 1.22 (1.01–1.47) 1.01 (0.83–1.22)
ICU use
Yes 1.33 (0.95–1.87) 1.51 (1.07–2.14)
No 1.00 1.00
Number of hospital admission
0 1.00 1.00
1 1.50 (1.31–1.72) 1.38 (1.20–1.58)
2 1.51 (1.24–1.83) 1.60 (1.31–1.96)
3 1.99 (1.66–2.38) 1.94 (1.60–2.34)
Respiratory impairment grade
Grade 1 (%FEV125 or Pa,O2 <55 mmHg) 0.90 (0.73–1.10) 1.42 (1.14–1.77)
Grade 2 (%FEV135 or Pa,O2 <60 mmHg) 0.82 (0.66–1.01) 1.17 (0.94–1.45)
Grade 3 (%FEV140 or Pa,O2 <65 mmHg) 0.71 (0.58–0.87) 0.99 (0.80–1.22)
None (%FEV1and Pa,O2 = Normal) 1.00 1.00
COC indexc
High (COC index0.75) 1.00 1.00
Low (COC index<0.75) 1.26 (1.13–1.41) 1.22 (1.09–1.36)
ICU, Intensive Care Unit; %FEV1, FEV1 predicted; COC, Continuity of Care.
a adjusted for age, sex, age, sex, health insurance type, use of home oxygen therapy, Charlson comorbidity index, ICU use, number of hospital
admissions, and respiratory impairment grade.
b Calculated comorbidity scores; extracted age scores.
c Time-dependent covariate; COC index ranged from 0 to 1; 1 means that one patient has visited only one physician.
doi:10.1371/journal.pone.0141465.t002
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patient knowledge, improving interpersonal communication, and increasing the likelihood
that patients adhere to their doctors’ advice [29]. Another study found that the benefits of con-
tinuity may be magnified in patients with chronic disease, because patients with chronic disease
are more likely than healthy people to use outpatient services and may establish relationships
with their physicians more quickly [30]. In another aspect, there was the possibility that
patients with uncontrolled or severe COPD visited another institution, when their condition
were doing poorly or were not stable. Because we used claims data, we could not distinguish
that patients who visited several different institutions were whether their condition were worse
or they did doctor shopping although their condition was stable.
Adjusted median survival time of patients receiving home oxygen therapy was 1.34 years
longer than those without. An analysis of unadjusted median survival time indicated that the
survival of patients with home oxygen therapy was better for the first 5 years, but afterwards
survival of patients without home oxygen therapy was better. This result suggests that home
oxygen therapy may be effective in prolonging survival. We controlled use of home oxygen
therapy according to literature which home oxygen therapy was associated with better survival
in COPD patients with severe hypoxemia such as Pa,O2 was 60 mmHg or less. Because home
oxygen therapy is usually indication to severe COPD patients, home oxygen use might be a
marker for much sicker patients with poorer expected survival. So we identified the association
between home oxygen therapy use and survival stratified to respiratory impairments (S1
Table). Only in severe respiratory impairment group with grade 1 of respiratory disability,
home oxygen therapy use was associated with decreasing the risk of all-cause mortality. In the
other groups, there was not statistically significant difference.
This study has some limitations. The first is that we used all-cause deaths to measure mor-
tality. We were not able to limit our analysis to only COPD-related deaths because cause of
death was not included in the health insurance qualification database. As a result, mortality as
measured in this study may not be directly related to continuity of ambulatory care received by
COPD patients. The second limitation is the accuracy of COPD diagnosis. We used NPS data,
which are based on information in the KNHI claims database. The accuracy of diagnosis in
KNHI claims data is about 70%. To increase accuracy, a review of all prescriptions would be
required. Unfortunately, we could not perform such a review. Thus, the accuracy of COPD
diagnoses in this study may have been compromised. Also, because we only included the
patients who visited more than 4 times due to COPD per each year to identify real COPD
patients and calculate COC index, it might be included a little severe COPD patients and our
results could not reflect the characteristics of patients with fewer than four ambulatory visits.
The third limitation involves the definition of newly diagnosed patients. In this study, they
were identified as patients who did not have COPD claims in 2002–2004 but had a COPD
claim in 2005. Thus, patients diagnosed prior to 2002 that did not utilize COPD-related medi-
cal services in 2002–2004 may have been included in the sample. The fourth limitation is that
we could not consider all factors that might affect the association between COC and mortality,
such as body mass index, income level, education, residential area, and health behaviors, due to
limitations of the claims database. Especially, health behaviors such as smoking and broncho-
spasm are highly related, but we could not identify. The fifth limitation is that our results do
not reflect characteristics of patients with fewer than four ambulatory visits per year. We
excluded such patients to increase the validity of our measurement of continuity. For example,
in some cases where actual continuity was not good, a continuity value could be relatively high
because a patient visited the same physician twice in a year. We excluded such individuals to
optimize accurate estimation of COC. The final limitation is that we could not identify individ-
ual service providers on the basis of information from the claims database. Hence, in this
study, outpatient healthcare provider was not a physician but a medical institution.
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Despite these limitations, our study has several strengths. First, we analyzed COPD patients
using nationwide claims data and conducted long-term follow up from 2005–2012. Although
many patients were excluded to increase the validity of our COC measure, our study popula-
tion was relatively large compared to previous studies evaluating the association between oxy-
gen therapy and mortality [21, 22]. Furthermore, to avoid time-dependent bias, we used a
longitudinal study design and treated COC as a time-dependent variable when investigating
the association between continuity of ambulatory care and mortality. In addition, we included
several proxy variables of health status in our models, such as ICU use, respiratory impairment
grade, and number of visits to the hospital admission department. Inclusion of such variables
may decrease bias due to confounding. Finally, one strength of this study was that we were able
to increase the homogeneity of our study sample by identifying newly diagnosed patients.
In conclusion, our results support the hypothesis that improving COC can reduce mortality
risk in patients with COPD. We should encourage policymakers to recognize the need for an
effective healthcare delivery system that promotes COC by encouraging a team approach and
enhancing accessibility.
Conclusion
The risk of mortality for patients with COPD declines with increasing COC. In addition, home
oxygen therapy and number of visits to the hospital admission department predict mortality in
patients with COPD. Further research on the associations between COC and various healthcare
outcomes, adjusting for potential confounders such as income, education, and health behav-
iors, is needed.
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